Pfizer Inc and BioNTech SE on Tuesday asked U.S. health regulators to authorize their COVID-19 vaccine in kids aged 5 to 11. The application to the U.S. Food and Drug Administration comes as COVID-19 infections have soared in children, hitting their highest point in early September, according to data from the American Academy of Pediatrics.
Oman Observer is now on the WhatsApp channel. Click here
